WCG partnered with Deep 6 AI to match patients to trials using NLP across 2,000 healthcare facilities.
Most trials fail to recruit enough participants because patients and physicians lack awareness and sponsors struggle to find eligible candidates. WCG combined its network of 3,300+ institutions and sites with Deep 6 AI's NLP and machine learning matching across data from 2,000 facilities covering 28 million patients. The article gives no outcome figures.
Deep 6 AI is a clinical trial patient-finding company that uses natural language processing on medical records to identify eligible patients for hospitals and sponsors
This sits in the Build stage of the AI use-case lifecycle: Named examples from the foundation-model labs and platforms pharma teams use to actually construct, train and generate the model or application.
Published by Deep 6 AI on its own site — read the original case study on bioxconomy.com ↗
Note: Partnership announcement from trade press; no results given.
Related use cases
- 01OpenAI's dedicated healthcare vertical page/launch post.
- 02Frontier reasoning model built for biology, drug discovery and translational medicine; named qualified customers include Amgen, Moderna, Allen Institute, and Thermo Fisher Scientific.
- 03follow-up update to the life-sciences model.
- 04"How Amgen uses GPT-5": Amgen applies GPT-5/frontier models to help accelerate delivery of potential new therapies; found GPT-5 met scientific-accuracy standards.
- 05Moderna and OpenAI partner to accelerate development of treatments; ChatGPT Enterprise deployed to thousands of employees company-wide.
- 06Longevity biotech collaborated with OpenAI to build and research GPT-4b micro, a version of GPT-4o specialized for protein engineering.